These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 28571765

  • 1. Potential of synthetic endoperoxides against Trichomonas vaginalis in vitro.
    Seo MY, Ryu JS, Sato A, Kurosaki Y, Chang KS, Kim HS.
    Parasitol Int; 2017 Oct; 66(5):619-621. PubMed ID: 28571765
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Drug library screening against metronidazole-sensitive and metronidazole-resistant Trichomonas vaginalis isolates.
    Goodhew EB, Secor WE.
    Sex Transm Infect; 2013 Sep; 89(6):479-84. PubMed ID: 23794105
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Stage specific activity of synthetic antimalarial endoperoxides, N-89 and N-251, against Plasmodium falciparum.
    Morita M, Koyama T, Sanai H, Sato A, Hiramoto A, Masuyama A, Nojima M, Wataya Y, Kim HS.
    Parasitol Int; 2015 Feb; 64(1):113-7. PubMed ID: 25449979
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The activity of protease inhibitors against Giardia duodenalis and metronidazole-resistant Trichomonas vaginalis.
    Dunn LA, Andrews KT, McCarthy JS, Wright JM, Skinner-Adams TS, Upcroft P, Upcroft JA.
    Int J Antimicrob Agents; 2007 Jan; 29(1):98-102. PubMed ID: 17137752
    [Abstract] [Full Text] [Related]

  • 8. Mycoplasma hominis infection of Trichomonas vaginalis is not associated with metronidazole-resistant trichomoniasis in clinical isolates from the United States.
    Butler SE, Augostini P, Secor WE.
    Parasitol Res; 2010 Sep; 107(4):1023-7. PubMed ID: 20652315
    [Abstract] [Full Text] [Related]

  • 9. In vitro effect of octenidine dihydrochloride against Trichomonas vaginalis.
    Küng E, Pietrzak J, Klaus C, Walochnik J.
    Int J Antimicrob Agents; 2016 Mar; 47(3):232-4. PubMed ID: 26899578
    [Abstract] [Full Text] [Related]

  • 10. Potential of bisbenzimidazole-analogs toward metronidazole-resistant Trichomonas vaginalis isolates.
    Korosh T, Bujans E, Morada M, Karaalioglu C, Vanden Eynde JJ, Mayence A, Huang TL, Yarlett N.
    Chem Biol Drug Des; 2017 Oct; 90(4):489-495. PubMed ID: 28296056
    [Abstract] [Full Text] [Related]

  • 11. High rates of double-stranded RNA viruses and Mycoplasma hominis in Trichomonas vaginalis clinical isolates in South Brazil.
    da Luz Becker D, dos Santos O, Frasson AP, de Vargas Rigo G, Macedo AJ, Tasca T.
    Infect Genet Evol; 2015 Aug; 34():181-7. PubMed ID: 26160539
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. In vitro inhibition of Toxoplasma gondii by the anti-malarial candidate, 6-(1,2,6,7-tetraoxaspiro[7.11]nonadec-4-yl)hexan-1-ol.
    Xin CF, Kim HS, Sato A, Lee HJ, Lee YW, Pyo KH, Shin EH.
    Parasitol Int; 2016 Oct; 65(5 Pt A):494-9. PubMed ID: 27380994
    [Abstract] [Full Text] [Related]

  • 14. The Role of Iron Status in the Early Progression of Metronidazole Resistance in Trichomonas vaginalis Under Microaerophilic Conditions.
    Argáez-Correa W, Alvarez-Sánchez ME, Arana-Argáez VE, Ramírez-Camacho MA, Novelo-Castilla JS, Coral-Martínez TI, Torres-Romero JC.
    J Eukaryot Microbiol; 2019 Mar; 66(2):309-315. PubMed ID: 30047563
    [Abstract] [Full Text] [Related]

  • 15. Activity of disulfiram (bis(diethylthiocarbamoyl)disulphide) and ditiocarb (diethyldithiocarbamate) against metronidazole-sensitive and -resistant Trichomonas vaginalis and Tritrichomonas foetus.
    Bouma MJ, Snowdon D, Fairlamb AH, Ackers JP.
    J Antimicrob Chemother; 1998 Dec; 42(6):817-20. PubMed ID: 10052908
    [Abstract] [Full Text] [Related]

  • 16. In vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis.
    Adagu IS, Nolder D, Warhurst DC, Rossignol JF.
    J Antimicrob Chemother; 2002 Jan; 49(1):103-11. PubMed ID: 11751773
    [Abstract] [Full Text] [Related]

  • 17. The effect of iron on metronidazole activity against Trichomonas vaginalis in vitro.
    Elwakil HS, Tawfik RA, Alam-Eldin YH, Nassar DA.
    Exp Parasitol; 2017 Nov; 182():34-36. PubMed ID: 28935536
    [Abstract] [Full Text] [Related]

  • 18. 5-Nitroimidazole drugs effective against metronidazole-resistant Trichomonas vaginalis and Giardia duodenalis.
    Upcroft JA, Dunn LA, Wright JM, Benakli K, Upcroft P, Vanelle P.
    Antimicrob Agents Chemother; 2006 Jan; 50(1):344-7. PubMed ID: 16377707
    [Abstract] [Full Text] [Related]

  • 19. The effect of 3-(biphenyl-4-yl)-3-hydoxyquinuclidine (BPQ-OH) and metronidazole on Trichomonas vaginalis: a comparative study.
    Rocha DA, de Andrade Rosa I, Urbina JA, de Souza W, Benchimol M.
    Parasitol Res; 2014 Jun; 113(6):2185-97. PubMed ID: 24752367
    [Abstract] [Full Text] [Related]

  • 20. A systematic review of the literature on mechanisms of 5-nitroimidazole resistance in Trichomonas vaginalis.
    Graves KJ, Novak J, Secor WE, Kissinger PJ, Schwebke JR, Muzny CA.
    Parasitology; 2020 Nov; 147(13):1383-1391. PubMed ID: 32729451
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.